Oracle Health Clinical AI Agent

Graded on the established platform not algorithm precedent applied to ModMed and Elation Health in this same category. The agent is genuinely generative, but the moat is the Oracle Health electronic health record and its installed base rather than the model, and no organisation buys Oracle Health because of this agent. The grade describes the mechanism, not the quality of the tool. Worth re checking on refresh: the next generation Oracle Health EHR is positioned as voice first with AI embedded directly in workflow rather than bolted alongside it, which would move this grade if the model becomes the reason the platform is chosen.

The sharpest oversight question in the ambient category, and the disclosure does not match the reach. Since February 2026 the agent drafts prescriptions, laboratory tests, imaging studies and follow up appointments from ambient listening, inferring dose, frequency and preferred pharmacy from patient history and clinician favourites. Drafting a medication order from overheard conversation is a materially different risk surface from drafting a note, because an error is a clinical action rather than a text correction. Oracle describes output as ready to review, so a human remains in the loop, but no confidence threshold, no order level accuracy rate, no abstention behaviour and no description of what happens when the conversation is ambiguous have been published. Most autonomous, least disclosed, the same pattern this index graded C for Hello Patient.

No model card, no named models, no published limitations and no accuracy figures for either note or order generation. Capability is described in unfalsifiable terms such as advanced reasoning and semantic understanding. Oracle's own product page carries a forward looking disclaimer stating that the content outlines general product direction, is for information purposes only, may not be incorporated into any contract, and that the nature and extent of AI assistance may evolve and is subject to change. A buyer cannot determine from published material where this system degrades.

The only published figure is customer reported time saved, more than 200,000 hours of documentation time for United States doctors as of February 2026. That is an adoption aggregate relayed by the vendor, not a study: no denominator of clinicians, no comparison group, no peer reviewed publication and no accuracy evaluation located. Graded C on the standing precedent in this index that scale of use does not substitute for evidence of benefit, the same call applied to Infervision, QuantHealth and Anterior.

Not assessed. No product specific statement on training data use, audio and transcript retention, or de identification was located in this verification pass. Given that the input is recorded clinical conversation and the output now includes prescription orders, this is the highest value axis to close on refresh.

Not assessed. Oracle Health operates as a covered service provider to United States health systems, but no product specific business associate agreement posture for this agent was retrieved in this pass and this index does not assert terms it has not seen.

Not assessed. No product level attestation for the agent was located in this pass, distinct from Oracle's general cloud compliance programme.

Not a regulated medical device and no clearance is claimed. One distinction worth holding, because buyers conflate the two: Oracle released the next generation ambulatory EHR pending final regulatory approvals, which refers to health IT certification rather than any FDA review of the AI. Certification of the record system says nothing about the safety of the agent writing into it.

No fairness, subgroup or accent and dialect statement located, which is a notable absence for a voice first product. What Oracle does publish on the subject is a disclaimer rather than a disclosure: that AI assistance may evolve over time and is subject to change, and that product descriptions may not be incorporated into any contract. That allocates risk away from the vendor without telling a buyer anything about how the system behaves. Contrast Microsoft Dragon Copilot in this same category, which names accent and dialect underperformance explicitly.

Depth is high and breadth is nil, which is the whole shape of this product. The agent is native to Oracle Health, embedded in clinician workflow rather than launched alongside it, and now writes structured orders back into the record rather than pasting text. It is also unavailable to anyone not on Oracle Health, so it competes only inside that installed base. For an Oracle site this is the strongest possible integration; for anyone else it is not a candidate.

Not assessed. Delivered as cloud service within the Oracle Health stack, but no residency detail specific to this agent was retrieved in this pass.

No published rate card and no standalone price. The agent is sold within the Oracle Health relationship, so its cost is embedded in an enterprise EHR contract and is not separable or comparable from outside. That is the structural reason bundled incumbent pricing cannot be benchmarked against the per provider per month figures the pure plays are quoted at.

Bounded and partly forward looking. Confirmed available to United States ambulatory providers, with order creation also United States only. Acute care functionality has been announced for 2026 rather than confirmed shipped in this pass. No specialty count or language coverage published, which is a gap relative to the pure play vendors in this category that enumerate both.